Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 25.9% year on year to $266 million. On the other ...
The transaction represented 2% of the insider's total direct equity holdings in the company. The activity involved the exercise of 3,313 options at $49.51 per share with an immediate open-market sale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results